Publications
Publications
  • February 2002
  • Case
  • HBS Case Collection

NeuroTherapy Ventures: Catalyzing Neurologic Innovations

  • Format:Print
  • | Pages:22
ShareBar

Abstract

Discusses the impact of limited market size on epilepsy therapies and shows how an early-stage venture fund can catalyze faster development of new treatments.

Keywords

Information Technology; Commercialization; Innovation and Management; Business Startups; Pharmaceutical Industry

Citation

Chesbrough, Henry W. "NeuroTherapy Ventures: Catalyzing Neurologic Innovations." Harvard Business School Case 602-124, February 2002.

More from the Author